These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1973370)

  • 21. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain.
    Schriefer A; Maltez JR; Silva N; Stoeckle MY; Barral-Netto M; Riley LW
    Vaccine; 1999 Feb; 17(7-8):770-8. PubMed ID: 10067682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospects for the development of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (3)].
    Cravioto A
    Bol Med Hosp Infant Mex; 1984 May; 41(5):253-61. PubMed ID: 6147148
    [No Abstract]   [Full Text] [Related]  

  • 24. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
    Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs.
    Morona R; Morona JK; Considine A; Hackett JA; van den Bosch L; Beyer L; Attridge SR
    Vaccine; 1994 May; 12(6):513-7. PubMed ID: 7913567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope selection and design of synthetic vaccines. Molecular approaches to enhancing immunogenicity and cross-reactivity of engineered vaccines.
    Berzofsky JA
    Ann N Y Acad Sci; 1993 Aug; 690():256-64. PubMed ID: 7690214
    [No Abstract]   [Full Text] [Related]  

  • 27. [Structural and functional specificity of the Dichelobacter nodosus pili. Synthesis of the protein pilin of D. nodosus in various bacterial recombinant strains].
    Zaberezhnyĭ AD; Grabovetskiĭ VV; Panasiuk SD; Alekseeva SV
    Mol Gen Mikrobiol Virusol; 2009; (4):3-6. PubMed ID: 20050159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of the virulence determinants of enterotoxigenic Escherichia coli isolated from domestic animals: applications for vaccine development.
    Dougan G; Morrissey P
    Vet Microbiol; 1985 Apr; 10(3):241-57. PubMed ID: 2860751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of the Escherichia coli fimbrial antigen K99 when expressed by Salmonella enteritidis 11RX.
    Bertram EM; Attridge SR; Kotlarski I
    Vaccine; 1994 Nov; 12(15):1372-8. PubMed ID: 7887013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against gonorrhoea: the potential protective effect of immunization with a synthetic peptide containing a conserved epitope of gonococcal outer membrane protein IB.
    Heckels JE; Virji M; Tinsley CR
    Vaccine; 1990 Jun; 8(3):225-30. PubMed ID: 1694611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress towards a vaccine against enterotoxigenic Escherichia coli.
    Kaper JB; Levine MM
    Vaccine; 1988 Apr; 6(2):197-9. PubMed ID: 2898844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.
    O'Hanley P; Lark D; Falkow S; Schoolnik G
    J Clin Invest; 1985 Feb; 75(2):347-60. PubMed ID: 2857730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibody response in mice, rabbits and pigs in response to vaccination with an inactivated oil vaccine containing rotavirus and Escherichia coli strains with K88, K99 and 987P fimbrial antigens].
    Zuffa A; Salajka E; Zajac J; Salajková Z; Zuffa T; Alexa P
    Vet Med (Praha); 1991 Jul; 36(7):423-31. PubMed ID: 1686823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of an Escherichia coli (serotype O1) pili vaccine in chickens.
    Gyimah JE; Panigrahy B
    Avian Dis; 1985; 29(4):1078-83. PubMed ID: 2870705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.
    Cachia PJ; Kao DJ; Hodges RS
    J Mol Recognit; 2004; 17(6):540-57. PubMed ID: 15386623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MAP system. A flexible and unambiguous vaccine design of branched peptides.
    Nardelli B; Tam JP
    Pharm Biotechnol; 1995; 6():803-19. PubMed ID: 7551249
    [No Abstract]   [Full Text] [Related]  

  • 37. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 38. The excretion of F18+ E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate.
    Tiels P; Verdonck F; Coddens A; Goddeeris B; Cox E
    Vaccine; 2008 Apr; 26(17):2154-63. PubMed ID: 18543416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous and common epitopes present in fimbriae of enterotoxigenic Escherichia coli (ETEC)].
    López-Vidal Y
    Gac Med Mex; 1997; 133(6):511-25. PubMed ID: 9504082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunisation of volunteers with a synthetic peptide vaccine for enterotoxigenic Escherichia coli.
    Klipstein FA; Engert RF; Houghten RA
    Lancet; 1986 Mar; 1(8479):471-2. PubMed ID: 2869210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.